Experience Stern | News & Events

Excerpt from Clinical Leader -- "But will the ruling promote competition and consumer welfare, or will it have the exact opposite effect? Attorneys from the law firm Ballard Spahr, along with Melissa Schilling, a professor from New York University’s Stern School of Business, have filed an amicus brief on behalf of 12 leading professors of management, organization, and policy supporting an appeal of the district court ruling. The brief notes the high cost of research and development will result in the injunction having the opposite effect. According to the brief, 'To the contrary, it is inefficient and anti-competitive to force a company to continue to support a product that it has replaced and for which the government’s witness agrees there is no 'market need.'"

Read more